Coppell Advisory Solutions LLC Intra Cellular Therapies, Inc. Transaction History

Coppell Advisory Solutions LLC

  • $680 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$46.37 - $73.65 $26,987 - $42,864
-582 Reduced 65.32%
309 $22.1 Million
Q3 2023

Nov 14, 2023
BUY
$52.09 - $64.1 $46,412 - $57,113
891 New
891 $47.2 Million
Q1 2023

May 19, 2023
SELL
$43.8 - $56.99 $39,025 - $50,778
-891 Closed
0 $0
Q4 2022

May 19, 2023
BUY
$44.07 - $54.45 $39,266 - $48,514
891 New
891 $47.2 Million

Others Institutions Holding ITCI

# of Institutions
378
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.92B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Coppell Advisory Solutions LLC Portfolio

Follow Coppell Advisory Solutions LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coppell Advisory Solutions LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email